✦ LIBER ✦

Synergistic effect of the anti-HER-2/neu antibody and cisplatin in immortalized and primary mesothelioma cell lines

✍ Scribed by Salvatore Toma; Lucia Colucci; Linda Scarabelli; Angelo Scaramuccia; Laura Emionite; Pier Giacomo Betta; Luciano Mutti

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 172 KB
Volume: 193
Category: Article
ISSN: 0021-9541
DOI: 10.1002/jcp.10150

No coin nor oath required. For personal study only.

✦ Synopsis

Malignant mesothelioma (MM) still remains a therapeutic and diagnostic problem to which new therapeutic perspectives are being continuously tried and tested. Three different primary cultures (MMGe-1, MES MM 98, and MES 1) and one immortalized cell line (MSTO 211 H) of human MM were studied in order to evaluate the HER-2/neu expression. Three out of four cell lines showed a different level of c-erbB-2 expression, the highest being detected on the MSTO 211 H cell line (fibroblastic phenotype), whereas MMGe-1 resulted negative. The effect of the anti-HER-2/neu antibody (Trastuzumab) alone, and in combination with cisplatin (CDDP) at different doses (ranging from 0.1 to 100 microg/ml), was studied on all the c-erB-2 positive cell lines. Trastuzumab was able to inhibit cell proliferation in a time-dependent manner, with growth inhibition also obtained at low concentrations (0.1-1 microg/ml). Combined treatment with Trastuzumab (10 microg/ml) and CDDP (1 microg/ml) showed synergism. Our results were encouraging, and suggest a rationale for further investigations in a clinical setting.

📜 SIMILAR VOLUMES

Targeting endothelin A receptor enhances

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

✍ Jeanett Fischgräbe; Martin Götte; Katharina Michels; Ludwig Kiesel; Pia Wülfing 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev

A synergistic effect between anti-idioty

A synergistic effect between anti-idiotype antibodies and anti-neoplastic drugs in the therapy of a murine B-cell tumor

✍ E. Hurwitz; D. Burowski; R. Kashi; N. Hollander; J. Haimovich 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 French ⚖ 767 KB

Antibodies directed against idiotypic determinants of the cell-surface IgM of a 6 lymphoma, 38c. were effective in delaying development of the tumor and in some instances in preventing its growth. The efficacity of the anti-idiotype antibodies was markedly increased when they were injected in combin

Effects of the tyrosine-kinase inhibitor

Effects of the tyrosine-kinase inhibitor geldanamycin on ligand-induced HER-2/NEU activation, receptor expression and proliferation of HER-2-positive malignant cell lines

✍ Frank Hartmann; Eva M. Horak; Cheryl Cho; Ruth Lupu; Joseph B. Bolen; Mary A. St 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB 👁 2 views

Geldanamycin belongs to the family of benzoquinoid ansamycin tyrosine-kinase inhibitors. We have examined its effects on Her-2/neu kinase activity, protein expression level, and proliferation of Her-2+ malignant cells. In SK-BR-3 breast-cancer cells, short-time treatment with geldanamycin completely

Signals involved in T cell activation. T

Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies

✍ René A. W. Van Lier; Miranda Brouwer; Lueien A. Aarden 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

Monoclonal antibodies (mAb) directed against the T cell differentiation antigen CD28 (Tp44) induce proliferation of resting T lymphocytes in the presence of phorbol esters. Moreover, it has been reported that such antibodies augment and sustain T cell proliferation induced by soluble antigens, phyto

Both the epitope specificity and isotype

Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen

✍ Kwang-Mi Kim; Eun-Young Shin; Jeoung-Hyun Moon; Tae-Hwe Heo; Joon Youb Lee; Yeon 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 516 KB

The Her-2/neu oncogene, which encodes a growth factor receptor, was implicated in the malignancy of human adenocarcinomas. Antibodies directed to this molecule have been previously shown to have an antitumor effect in vivo. In an attempt to understand the mechanisms of the antitumor activity, we gen

Inhibition of growth and induction of en

Inhibition of growth and induction of enzyme activities in a clonal human hepatoma cell line (Li-7A): Comparison of the effects of epidermal growth factor and an anti-epidermal growth factor receptor antibody

✍ Aileen F. Knowles 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB

A cloned human hepatoma cell line (Li-7A), possessing epidermal growth factor (EGF) receptors numbering in the range of 10-20 pmol/106 cells, was inhibited in its growth by EGF as well as an antagonist monoclonal antibody (MoAb) to the EGF receptor. The mode of action of the two ligands of EGF recep